Tatiana Segura

Segura

Professor of Biomedical Engineering

Professor Tatiana Segura received her BS degree in Bioengineering from the University of California Berkeley and her doctorate in Chemical Engineering from Northwestern University. Her graduate work in designing and understanding non-viral gene delivery from hydrogel scaffolds was supervised by Prof. Lonnie Shea. She pursued post-doctoral training at the Swiss Federal Institute of Technology, Lausanne under the guidance of Prof. Jeffrey Hubbell, where her focus was self-assembled polymer systems for gene and drug delivery. Professor Segura's Laboratory studies the use of materials for minimally invasive in situ tissue repair.   On this topic, she has published 113 peered reviewed publications to date. She has been recognized with the Outstanding Young Investigator Award from the American Society of Gene and Cell Therapy, the American Heart Association National Scientist Development Grant, and the CAREER award from National Science Foundation.  She was Elected to the College of Fellows at the American Institute for Medical and Biological Engineers (AIMBE) in 2017. She spent the first 11 years of her career at UCLA department of Chemical and Biomolecular Engineering and has recently relocated to Duke University, where she holds appointments in Biomedical Engineering, Neurology and Dermatology. 

Appointments and Affiliations

  • Professor of Biomedical Engineering
  • Professor in Neurology
  • Professor in Dermatology
  • Affiliate of the Duke Regeneration Center

Contact Information

  • Office Location: 534 Research Drive, Durham, NC 27708
  • Office Phone: (919) 660-2901
  • Email Address: tatiana.segura@duke.edu
  • Websites:

Education

  • Ph.D. Northwestern University, 2004

Research Interests

The design of biomaterials to promote endogenous repair and reducing inflammation through the design of the geometry of the material, and delivering genes, proteins and drugs.

Awards, Honors, and Distinctions

  • Fellow. American Institute for Medical and Biological Engineers. 2017
  • National Scientist Development Grant. American Heart Association. 2009
  • Outstanding Young Investigator Award. American Society of Gene and Cell Therapy. 2009
  • CAREER Award. National Science Foundation. 2008

Courses Taught

  • BME 394: Projects in Biomedical Engineering (GE)
  • BME 493: Projects in Biomedical Engineering (GE)
  • BME 771: Bioconjugation in drug biomaterials and drug delivery systems
  • BME 790: Advanced Topics for Graduate Students in Biomedical Engineering
  • BME 790L: Advanced Topics with the Lab for Graduate Students in Biomedical Engineering
  • BME 791: Graduate Independent Study
  • BME 792: Continuation of Graduate Independent Study
  • EGR 393: Research Projects in Engineering

In the News

Representative Publications

  • Kurt, E; Segura, T, Nucleic Acid Delivery from Granular Hydrogels., Adv Healthc Mater (2021) [10.1002/adhm.202101867] [abs].
  • Samal, J; Segura, T, Injectable biomaterial shuttles for cell therapy in stroke., Brain Research Bulletin, vol 176 (2021), pp. 25-42 [10.1016/j.brainresbull.2021.08.002] [abs].
  • Xi, W; Hegde, V; Zoller, SD; Park, HY; Hart, CM; Kondo, T; Hamad, CD; Hu, Y; Loftin, AH; Johansen, DO; Burke, Z; Clarkson, S; Ishmael, C; Hori, K; Mamouei, Z; Okawa, H; Nishimura, I; Bernthal, NM; Segura, T, Point-of-care antimicrobial coating protects orthopaedic implants from bacterial challenge., Nature Communications, vol 12 no. 1 (2021) [10.1038/s41467-021-25383-z] [abs].
  • Griffin, DR; Archang, MM; Kuan, C-H; Weaver, WM; Weinstein, JS; Feng, AC; Ruccia, A; Sideris, E; Ragkousis, V; Koh, J; Plikus, MV; Di Carlo, D; Segura, T; Scumpia, PO, Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing., Nature Materials, vol 20 no. 4 (2021), pp. 560-569 [10.1038/s41563-020-00844-w] [abs].
  • Escuin-Ordinas, H; Liu, Y; Sun, L; Hugo, W; Dimatteo, R; Huang, RR; Krystofinski, P; Azhdam, A; Lee, J; Comin-Anduix, B; Cochran, AJ; Lo, RS; Segura, T; Scumpia, PO; Ribas, A, Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects., Plos One, vol 16 no. 6 (2021) [10.1371/journal.pone.0252597] [abs].